HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yihan Li Selected Research
Yihan Li Research Topics
Disease
14
Rheumatoid Arthritis
01/2022 - 07/2016
9
Infections
01/2022 - 01/2013
6
Neoplasms (Cancer)
02/2022 - 01/2013
4
Pain (Aches)
12/2020 - 11/2019
3
Herpes Zoster
01/2022 - 01/2018
2
Osteoarthritis
12/2020 - 01/2020
2
Hypersensitivity (Allergy)
11/2018 - 11/2018
2
Psoriatic Arthritis
11/2018 - 11/2018
2
Major Depressive Disorder (Major Depressive Disorders)
12/2015 - 02/2012
2
Breast Neoplasms (Breast Cancer)
04/2014 - 04/2014
1
Chronic Disease (Chronic Diseases)
01/2023
1
Shock
11/2022
1
Bone Resorption
10/2022
1
Colorectal Neoplasms (Colorectal Cancer)
02/2022
1
Arteriosclerosis
01/2022
1
Venous Thromboembolism
01/2022
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1
Disease Progression
12/2021
1
Cognitive Dysfunction
12/2021
1
Rolandic Epilepsy (Centrotemporal Epilepsy)
10/2021
1
Ovarian Neoplasms (Ovarian Cancer)
10/2021
1
Epilepsy (Aura)
01/2021
1
Wounds and Injuries (Trauma)
11/2020
1
Weight Loss (Weight Reduction)
11/2020
1
Disease Resistance
09/2020
1
Hyperglycemia
09/2020
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2020
1
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2020
1
Colic (Abdominal Cramps)
01/2020
1
Intussusception
01/2020
1
Amyloidosis
01/2020
1
Absence Epilepsy (Childhood Absence Epilepsy)
01/2020
1
Osteoporosis
03/2019
1
Dehydration (Water Stress)
01/2019
1
Hyperplasia
01/2019
1
Experimental Arthritis
01/2019
1
Arthritis (Polyarthritis)
01/2019
Drug/Important Bio-Agent (IBA)
8
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 01/2018
7
upadacitinib
IBA
01/2022 - 01/2018
5
Adalimumab (Humira)
FDA Link
01/2022 - 01/2018
3
Collagen
IBA
10/2022 - 04/2014
3
Proteins (Proteins, Gene)
FDA Link
02/2022 - 04/2014
3
Interleukin-17 (Interleukin 17)
IBA
11/2018 - 11/2018
2
Janus Kinase Inhibitors
IBA
01/2022 - 01/2021
2
Antigens
IBA
10/2021 - 01/2013
2
Anticonvulsants (Antiepileptic Drugs)
IBA
10/2021 - 01/2021
2
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
12/2020 - 01/2020
2
huatan tongluo
IBA
01/2019 - 07/2016
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2019 - 01/2013
2
Therapeutic Uses
IBA
01/2019 - 07/2016
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2018 - 11/2018
2
C-Reactive Protein
IBA
11/2018 - 01/2018
2
ABT-122
IBA
11/2018 - 11/2018
2
Biological Products
IBA
01/2018 - 01/2014
1
Nitrites
IBA
11/2022
1
Wastewater
IBA
11/2022
1
Nitrogen
IBA
11/2022
1
Matrix Metalloproteinases (MMPs)
IBA
10/2022
1
Calnexin
IBA
02/2022
1
LDL Cholesterol
IBA
01/2022
1
hydroxide ion
IBA
01/2022
1
Anti-Citrullinated Protein Antibodies
IBA
01/2022
1
aducanumab
IBA
12/2021
1
donanemab
IBA
12/2021
1
lecanemab
IBA
12/2021
1
Small Interfering RNA (siRNA)
IBA
10/2021
1
Immune Sera (Antisera)
IBA
05/2021
1
Opioid Analgesics (Opioids)
IBA
12/2020
1
Nerve Growth Factor (NGF)
IBA
12/2020
1
Antibodies
IBA
12/2020
1
Adenosine Triphosphate (ATP)
IBA
11/2020
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
09/2020
1
S-methyl benzo(1,2,3)thiadiazole-7-carbothioate (acibenzolar-S-methyl)
IBA
09/2020
1
Mitogen-Activated Protein Kinases
IBA
09/2020
1
Cytokines
IBA
09/2020
1
Bortezomib (Velcade)
FDA Link
07/2020
1
Pharmaceutical Preparations
IBA
01/2020
1
Duloxetine Hydrochloride (Cymbalta)
FDA Link
01/2020
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
01/2020
1
Tramadol (K315)
FDA Link
Generic
01/2020
1
Interleukins
IBA
01/2020
1
Amyloid (Amyloid Fibrils)
IBA
01/2020
1
lutikizumab
IBA
01/2020
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
01/2020
1
Creatine Kinase (Creatine Phosphokinase)
IBA
11/2019
1
Gelatin
IBA
03/2019
1
Fibroins (Fibroin)
IBA
03/2019
1
Enzymes
IBA
03/2019
1
strontium ranelate (protelos)
IBA
03/2019
1
Charcoal (Charbon)
IBA
01/2019
1
Flame Retardants (Fire Retardants)
IBA
01/2019
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
01/2019
1
Titanium
IBA
01/2019
1
amsonic acid (DAS)
IBA
11/2018
Therapy/Procedure
4
Therapeutics
01/2023 - 11/2019
1
Immunotherapy
12/2021
1
Drug Therapy (Chemotherapy)
07/2020
1
Hematopoietic Stem Cell Transplantation
07/2020
1
Replantation
11/2019
1
Aftercare (After-Treatment)
01/2019